Table 1.
Gene symbol | Gene name (Downregulated by NAT) | Fold Change |
---|---|---|
LGALS3BP | lectin, galactoside-binding, soluble, 3 binding protein | 0.002 |
PCSK6 | proprotein convertase subtilisin/kexin type 6 | 0.006 |
LAMB3 | laminin, beta 3 | 0.007 |
ANXA2 | annexin A2 | 0.011 |
LAMC2 | laminin, gamma 2 | 0.012 |
EFNA5* | ephrin-A5* | 0.013 |
CASK | calcium/calmodulin-dependent serine protein kinase (MAGUK family) | 0.013 |
ITGA6 | integrin, alpha 6 | 0.021 |
MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.021 |
CD151 | CD151 molecule (Raph blood group) | 0.025 |
LAMA3 | laminin, alpha 3 | 0.025 |
PKM | pyruvate kinase, muscle | 0.028 |
PLOD3 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 | 0.031 |
SLPI | secretory leucocyte peptidase inhibitor | 0.031 |
PLAT | plasminogen activator, tissue | 0.032 |
LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.038 |
CST3 | cystatin C | 0.044 |
MMP28 | matrix metallopeptidase 28 | 0.047 |
COL7A1 | collagen, type VII, alpha 1 | 0.047 |
LOXL2 | lysyl oxidase-like 2 | 0.048 |
MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.051 |
IBSP | integrin-binding sialoprotein | 0.053 |
ACHE | acetylcholinesterase (Yt blood group) | 0.054 |
COL17A1 | collagen, type XVII, alpha 1 | 0.064 |
NDNF | neuron-derived neurotrophic factor | 0.070 |
DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.073 |
MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.089 |
TINAG | tubulointerstitial nephritis antigen | 0.093 |
BMP7 | bone morphogenetic protein 7 | 0.099 |
AGRIN | agrin | 0.102 |
MUC4 | mucin 4, cell surface associated | 0.175 |
DMBT1 | deleted in malignant brain tumours 1 | 0.176 |
EFNA5 is nominated as a candidate (*).